Roivant Sciences ROIV Ratios & Valuation
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| Efficiency | ||||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Liquidity | ||||||
| Current ratio | 123.3×-15.1× | 138.4×-7.2× | 145.6×+23.3× | 122.3×+12.6× | 109.7×+8.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×-0.1× | |
| Per Share | ||||||
| Book value per share | $25.45+0.2% | $25.38-4.0% | $26.44-2.2% | $27.04-2.1% | $27.60-2.5% | |
| Valuation | ||||||
| Market capitalization | $53.09B+31.2% | $40.47B+19.1% | $33.99B+5.7% | $32.15B+0.2% | $32.08B-3.8% | |
| Price / sales | 4,379.9×+2,152× | 2,227.6×+852× | 1,376×+279× | 1,097×+123× | 974.1×+78.1× | |
| Price / book | 12.1×+2.8× | 9.2×+1.9× | 7.4×+0.7× | 6.6×+0.4× | 6.3×+0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Roivant Sciences's ratios come from?
- Every ratio is computed from Roivant Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
